Loading organizations...
Loading organizations...
Bioscience company specializing in targeted cancer drug delivery.
EnGeneIC has raised $10.0M across 1 funding round.
EnGeneIC has raised $10.0M in total across 1 funding round.
EnGeneIC has raised $10.0M in total across 1 funding round.
EnGeneIC's investors include GRT Capital Partners, Foley Ventures.
EnGeneIC has raised $10.0M across 1 funding round. Most recently, it raised $10.0M Series B in January 2015.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 6, 2015 | $10.0M Series B | GRT Capital Partners | Foley Ventures |